Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-020802

CEO and President gave up 406 shares (to pay taxes)

  • CEO and President acquired 1,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KLEMP WALTER V CEO and President 2025-06-16 Option exercise +1,667 58,702 D
KLEMP WALTER V CEO and President 2025-06-16 Shares withheld for taxes −406 $0.69 $278 58,296 D
Derivatives
KLEMP WALTER V CEO and President 2025-06-16 Option exercise · Restricted Stock Units −1,667 370,075 D
Loading xslF345X05/rdgdoc.xml…